• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4例持续性非卧床腹膜透析患者中万古霉素的腹膜转运情况

Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.

作者信息

Pancorbo S, Comty C

出版信息

Nephron. 1982;31(1):37-9. doi: 10.1159/000182611.

DOI:10.1159/000182611
PMID:7110474
Abstract

The pharmacokinetics of vancomycin have been studied in 4 chronic renal failure patients undergoing continuous ambulatory peritoneal dialysis. Patients received 1 g of vancomycin in 2 liters of dialysate during an initial phase, and serum and dialysate samples were collected for vancomycin determination. 54% of the amount introduced into the peritoneal cavity were absorbed systemically during a 6-hour cycle. Peak serum concentrations averaged 23.7 microgram/ml. Mean elimination half-life was calculated to be 66.9 h, and dialysis clearance averaged 2.4 ml/min.

摘要

已对4名接受持续性非卧床腹膜透析的慢性肾衰竭患者的万古霉素药代动力学进行了研究。在初始阶段,患者在2升透析液中接受1克万古霉素,收集血清和透析液样本以测定万古霉素。在6小时的周期内,引入腹腔的药物量中有54%被全身吸收。血清峰值浓度平均为23.7微克/毫升。计算得出平均消除半衰期为66.9小时,透析清除率平均为2.4毫升/分钟。

相似文献

1
Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.4例持续性非卧床腹膜透析患者中万古霉素的腹膜转运情况
Nephron. 1982;31(1):37-9. doi: 10.1159/000182611.
2
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者中万古霉素的药代动力学
Antimicrob Agents Chemother. 1984 May;25(5):603-6. doi: 10.1128/AAC.25.5.603.
3
Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.慢性间歇性腹膜透析期间万古霉素的腹膜清除率及全身清除率
Clin Nephrol. 1979 Mar;11(3):129-32.
4
[Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].[腹腔内给药后持续非卧床腹膜透析(CAPD)慢性肾衰竭患者万古霉素的药代动力学]
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):542-4.
5
Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析患者中庆大霉素的药代动力学
Antimicrob Agents Chemother. 1981 Apr;19(4):605-7. doi: 10.1128/AAC.19.4.605.
6
Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.慢性间歇性腹膜透析患者的万古霉素药代动力学
Int J Clin Pharmacol Ther Toxicol. 1982 Dec;20(12):559-63.
7
Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.持续性非卧床腹膜透析期间万古霉素的处置:腹膜药物转运的药代动力学分析
Antimicrob Agents Chemother. 1985 Apr;27(4):578-82. doi: 10.1128/AAC.27.4.578.
8
Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis.夜间间歇性腹膜透析中小分子和中分子溶质清除率
Perit Dial Int. 1999 Nov-Dec;19(6):534-9.
9
Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者腹腔内头孢噻吩的血清及透析液浓度
Clin Nephrol. 1983 Jul;20(1):40-3.
10
Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.持续性非卧床腹膜透析相关性腹膜炎患者单次静脉注射万古霉素的药代动力学
J Antimicrob Chemother. 1987 Mar;19(3):351-7. doi: 10.1093/jac/19.3.351.

引用本文的文献

1
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.万古霉素在腹膜透析中的应用:治疗中的临床药理学考虑。
Perit Dial Int. 2020 Jul;40(4):384-393. doi: 10.1177/0896860819889774. Epub 2020 Feb 17.
2
Vancomycin: the tale of the vanquisher and the pyrrhic victory.万古霉素:征服者的故事与惨胜
Perit Dial Int. 2014 Mar-Apr;34(2):154-61. doi: 10.3747/pdi.2014.00001.
3
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者中万古霉素的药代动力学
Antimicrob Agents Chemother. 1984 May;25(5):603-6. doi: 10.1128/AAC.25.5.603.
4
Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.持续非卧床腹膜透析的药代动力学研究进展:文献综述
Pharm Weekbl Sci. 1984 Dec 14;6(6):229-36. doi: 10.1007/BF01954550.
5
Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.持续性非卧床腹膜透析期间万古霉素的处置:腹膜药物转运的药代动力学分析
Antimicrob Agents Chemother. 1985 Apr;27(4):578-82. doi: 10.1128/AAC.27.4.578.
6
Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.接受腹膜透析患者的药物治疗。临床药代动力学考量
Clin Pharmacokinet. 1985 Sep-Oct;10(5):404-25. doi: 10.2165/00003088-198510050-00003.
7
Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间腹腔内和静脉注射万古霉素药代动力学的比较研究
Antimicrob Agents Chemother. 1987 Feb;31(2):173-7. doi: 10.1128/AAC.31.2.173.
8
Clinical pharmacokinetics of vancomycin.万古霉素的临床药代动力学
Clin Pharmacokinet. 1986 Jul-Aug;11(4):257-82. doi: 10.2165/00003088-198611040-00001.
9
Co-trimoxazole (sulphamethoxazole plus trimethoprim) peritoneal barrier transfer pharmacokinetics.复方新诺明(磺胺甲恶唑加甲氧苄啶)腹膜屏障转运的药代动力学。
Clin Pharmacokinet. 1989 May;16(5):317-25. doi: 10.2165/00003088-198916050-00004.
10
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析中腹透液中万古霉素的清除及腹腔内万古霉素的平衡
Clin Pharmacokinet. 1990 Jun;18(6):485-90. doi: 10.2165/00003088-199018060-00005.